| Date | Title | Description | Source |
| 20.03.2024 |
Mainstay Medical Announces Publication of the First Neurom... | Groundbreaking ReActiv8-B study supports the long-term efficacy, safety and durability of ReActiv8® ... | fh-partner... |
| 13.03.2024 |
Mainstay Medical Announces Publication of Clinical Results... | Efficacy of ReActiv8® Restorative Neurostimulation™ shows no statistically or clinically meaningful ... | fh-partner... |
| 26.02.2024 |
Mainstay Medical Announces US$125 Million Equity Financing... | Funding to accelerate commercial growth and expand clinical and health economic evidence for ReActiv... | fh-partner... |
| 13.02.2024 |
Mainstay Medical Announces Receipt of FDA Approval for MRI... | U.S. patients implanted with ReActiv8 now eligible for full-body MRI scans
Mainstay Medical Holdi... | fh-partner... |
| 09.03.2021 |
Mainstay Medical Announces Commercial Launch of ReActiv8® ... | Mainstay Medical Holdings plc (“Mainstay” or the “Company”) today announced the commercial launch in... | fh-partner... |
| 08.03.2021 | Mainstay Medical announces commercial launch of ReActiv8® in... | Dublin, Ireland: 8 March 2021 – Mainstay Medical Holdings plc today announced the commercial launch ... | capricorn.... |
| 16.02.2021 | Mainstay Medical Holdings plc announced that it has received... | On February 16, 2021, Mainstay Medical Holdings plc closed the transaction. The company has raised g... | marketscre... |
| 16.02.2021 | Mainstay Medical Announces US$108 Million Equity Financing T... | Mainstay Medical Holdings plc (“Mainstay” or the “Company”) today announced the closing of an equity... | marketscre... |
| 16.02.2021 | Mainstay Medical Receives US$108M Equity Financing | Mainstay Medical Holdings, a Dublin, Ireland-based medical device company focused on commercializing... | finsmes.co... |
| 16.02.2021 | Mainstay Medical announces US$ 108 million equity financing ... | Funding to support U.S. commercial launch and global expansion | capricorn.... |
| 16.02.2021 | Mainstay Medical Announces US$108 Million Equity Financing T... | DUBLIN–(BUSINESS WIRE)–Feb 16, 2021–
Mainstay Medical Holdings plc (“ Mainstay ” or the “ Company ”)... | oaoa.com/l... |
| 16.02.2021 | Ally Bridge Group Co-leads Mainstay Medical’s $108 Million E... | Funding to support U.S. commercial launch and global expansion
DUBLIN–(BUSINESS WIRE)–Mainstay Medi... | ally-bridg... |
| 16.02.2021 |
Mainstay Medical Announces US$108 Million Equity Financing... | Mainstay Medical Holdings plc (“Mainstay” or the “Company”) today announced the closing of an equity... | fh-partner... |
| 25.01.2021 | Mainstay Medical announces key strategic Vice President hire... | Appointments to support upcoming commercial launch of ReActiv8 in the US and foster further growth i... | capricorn.... |
| 22.06.2020 | Mainstay Medical announces US FDA approval of ReActiv8® Neur... | Dublin, Ireland: 22 June 2020 – Mainstay Medical Holdings plc today announced that the US Food and D... | capricorn.... |
| 08.06.2020 | Mainstay Medical announces reimbursement approval for ReActi... | Dublin, Ireland: 8 June 2020 – Mainstay Medical Holdings plc today announced that ReActiv8, its impl... | capricorn.... |
| 17.01.2020 | PREDICT-LAA trial enrolls first patient | Ghent, Belgium: 17 January 2020 – FEops, a leader in personalized predictive planning for structural... | capricorn.... |
| 06.12.2019 | Mainstay Medical announces regulatory approval from Australi... | Dublin, Ireland: 6 December 2019 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and E... | capricorn.... |
| 01.10.2019 | Mainstay Medical announces acceptance for filing by US FDA o... | Dublin, Ireland: 1 October 2019 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and Eu... | capricorn.... |
| 30.07.2019 | Mainstay Medical announces completion of financing transacti... | • Funds to be used to support PMA process for ReActiv8® in US and to further European commercial val... | capricorn.... |
| 26.06.2019 | Mainstay Medical announces completion of pre-submission meet... | Dublin, Ireland: 26 June 2019 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and Euro... | capricorn.... |
| 18.04.2019 | Mainstay Medical provides company update and publishes 2018 ... | Dublin, Ireland: 18 April 2019 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and Eur... | capricorn.... |
| 21.09.2018 | Mainstay Medical announces 2018 half-year financial results ... | Dublin, Ireland: 21 September 2018 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and... | capricorn.... |
| 20.08.2018 | Mainstay Medical announces the appointment of Matthew Onaiti... | Dublin, Ireland: 20 August 2018 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and Eu... | capricorn.... |
| 09.07.2018 | Mainstay Medical announces the completion of all implants in... | Dublin, Ireland: 9 July 2018 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and Euron... | capricorn.... |
| 20.06.2018 | Mainstay Medical appoints Wolfgang Frisch as VP and Managing... | Dublin, Ireland: 20 June 2018 – Mainstay Medical International plc (“Mainstay” or the “Company”, Eur... | capricorn.... |
| 05.04.2018 | Mainstay’s Update on Regulatory Application for ReActiv8 in ... | Dublin, Ireland: 5 April 2018 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and ESM ... | capricorn.... |
| 15.02.2018 | Mainstay Medical announces € 30 million financing new capita... | Dublin, Ireland: 15 February 2018 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and ... | capricorn.... |
| 15.02.2018 | Mainstay Medical publishes 2017 full year results | Dublin, Ireland: 15 February 2018 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and ... | capricorn.... |
| 23.01.2018 | Mainstay confirms its continued eligibility to the PEA-PME | Dublin, Ireland: 23 January 2018 – Mainstay Medical International plc (listed on Euronext Paris: MST... | capricorn.... |
| 11.12.2017 | Mainstay Medical announces positive outcome of interim analy... | Dublin, Ireland: 11 December 2017 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and ... | capricorn.... |
| 23.03.2017 | Mainstay Medical Publishes 2016 Full Year Results and Busine... | 23 March 2017 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and ESM of the Irish Sto... | capricorn.... |
| 01.02.2017 | Mainstay Medical starts commercialization of ReActiv8® for t... | Dublin, Ireland: 1 February 2017 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and E... | capricorn.... |
| 24.01.2017 | Mainstay confirms its continued eligibility to the PEA-PME | Dublin, Ireland: 24 January 2017 – Mainstay Medical International plc (listed on Euronext Paris: MST... | capricorn.... |
| 12.01.2017 | Mainstay Medical Applies for Approval to Market ReActiv8® in... | Dublin, Ireland: 12 January 2017 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and E... | capricorn.... |
| 01.05.2014 | Report: Mainstay Medical’s IPO raises $25M | Mainstay Medical‘s (MSTY.PA) European initial public offering reeled in about $25 million (€18 milli... | massdevice... |
| - | Mainstay Medical | “Mainstay Medical is improving quality of life for patients with chronic low back pain through innov... | fastfounde... |
